SINOPHARM(CNCM LTD)(SH:600511) Shang Hai Zheng Quan Bao·2025-07-07 18:43Group 1 - The board of directors of China National Pharmaceutical Group Corporation (referred to as "the company" or "China National Pharmaceutical") held its 26th meeting of the 8th board on July 7, 2025, in Beijing, with all seven directors present, including four independent directors [2][3] - The meeting approved the election of Mr. Liu Yuetao as the chairman of the 8th board of directors with a unanimous vote of 7 in favor, 0 against, and 0 abstentions [3][4] - The board also approved adjustments to the members of its specialized committees to enhance decision-making and governance, with specific members assigned to the strategy, nomination, audit, and compensation committees [4] Group 2 - Mr. Liu Yuetao, who has a background in finance and has held various positions within the company, was elected as chairman and has been serving as the party secretary since June 2025 [6] - The company confirmed that Mr. Liu does not hold any shares in the company and has no conflicts of interest with other board members or significant shareholders [7] - The company’s first extraordinary general meeting of 2025 was also held on July 7, 2025, with all resolutions passed unanimously [8][9]